Prevention and Management of Recurrent Diaper Candida Infections

Primary Prevention Strategies

• Keeping the diaper area dry between changes by allowing air exposure when feasible and avoiding occlusive barriers that trap moisture is recommended 1
• Sterilizing all items that contact the diaper area, including pacifiers, bottles, and toys regularly during and after treatment, can help prevent reinfection 2
• Evaluating for maternal vaginal candidiasis if the mother is breastfeeding or has close contact with the infant, as treatment prior to or during infant care may prevent colonization, is suggested by the Clinical Microbiology and Infection guidelines 3, 2

Prophylactic Antifungal Considerations

• The ESCMID guidelines recommend oral nystatin for neonates <1500g to reduce fungal infection, though this had no mortality benefit and carries concerns for potential gut damage 4, 5, 6, 7, 8, 9, 10
• Fluconazole prophylaxis is only recommended for extremely high-risk neonates <1000g in NICUs with high invasive candidiasis rates (>10%) 4, 5, 6, 7, 8, 9, 10, 3

Risk Factor Modification

• Minimizing broad-spectrum antibiotic use, particularly third-generation cephalosporins and carbapenems, which are significant risk factors for Candida overgrowth, is advised 12, 3
• Evaluating for underlying conditions such as diabetes mellitus or other metabolic conditions, chronic diarrhea or malabsorption syndromes, can help identify predisposing factors 2, 12

Treatment Algorithm for Acute Recurrences

• First-line treatment with topical nystatin cream/ointment applied to affected areas 2-3 times daily for 7-14 days is recommended 13, 2
• Alternative treatment with miconazole oral gel 15mg Q8h has higher cure rates compared to nystatin gels 13, 2
• For resistant cases, oral fluconazole 3-6 mg/kg daily for 7 days may be considered 13, 2

Common Pitfalls to Avoid

• Avoiding prolonged systemic azole therapy in otherwise healthy infants due to resistance concerns and lack of evidence in this population is recommended by the American family physician guidelines 11, 3